Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)
Status:
Withdrawn
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double-blinded, placebo-controlled, pilot study to assess
the preliminary efficacy and safety of hydroxychloroquine for the treatment of patients with
lower respiratory tract SARS-CoV-2 infection.